New Delhi: Travellers vaccinated with Covishield, manufactured by Pune-based Serum Institute of India (SII), may not be eligible for the European Union ‘Green Pass’, being launched to enable easy travel into and between EU countries.
The digital “vaccine passport” recognises the Vaxzevria version of the AstraZeneca vaccine that is produced in the UK and Europe, and approved by the European Medicines Agency (EMA). Covishield, manufactured by the Serum Institute of India, is not yet recognised by the EMA.
Many EU member states have started issuing the digital “vaccine passport” that will enable Europeans to move freely for work or tourism. The immunity passport will serve as proof that a person has been vaccinated against the coronavirus disease (Covid-19), or recently tested negative for the virus, or has the natural immunity built up from earlier infection.
